Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
NCT06333782

Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation

Led by Bioscience Cosmetics SL · Updated on 2024-08-09

110

Participants Needed

3

Research Sites

57 weeks

Total Duration

On this page

Sponsors

B

Bioscience Cosmetics SL

Lead Sponsor

E

Eurofins

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this interventional clinical investigation using Genefill Contour® CE marked device outside of its indication is to compare with other hyaluronic acid device already marketed for labia majora augmentation in women with labia majora hypotrophy/atrophy. The primary objective is the evaluation of the safety of Genefill Contour®. The secondary objectives is effectivenes of the investigational device (improvement of patient´s symptoms, patient´s satisfaction, sexual function \& pain during injection). Participants will come to a total of 8 visits (including 2 phone calls) over a period of 12 months. Participants would be enrolled in Genefill Contour® or comparator group. An ancillary study would be conducted in a cohort of participants evaluating the increase in volume and distance between labia after HA injection

CONDITIONS

Official Title

Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female gender.
  • Age over 18 years.
  • Diagnosed with labia majora atrophy or hypotrophy and desire volume augmentation.
  • Able to understand and sign informed consent.
  • Provided free and informed consent.
  • Affiliated to a health social security system.
  • If of childbearing potential, using effective contraception for at least 12 weeks before and during the study.
Not Eligible

You will not qualify if you...

  • Pregnant, breastfeeding, or planning pregnancy during the study.
  • Gave birth within 4 months before inclusion.
  • Deprived of freedom by legal decision or under guardianship.
  • Residing in social or sanitary establishment.
  • Judged non-compliant by investigator.
  • Suffering from severe or progressive disease.
  • History of autoimmune disease.
  • Immunosuppressed.
  • Having haemostatic disorder.
  • Presenting acute or chronic skin diseases.
  • Active inflammatory or infectious processes near labia majora.
  • Bacterial, fungal, or viral infection near labia majora.
  • History of streptococcal disease.
  • Recurrent genital herpes (except if asymptomatic for 6 months before inclusion).
  • History of pre-cancerous condition or cancer near injection site.
  • Current cancer or vulvar dysplasia.
  • Known tendency to develop keloid or hypertrophic scars.
  • Known allergy or hypersensitivity to hyaluronic acid, Genefill Contour, Desirial� Plus, anesthesia, or disinfectants.
  • Multiple allergies.
  • Condition or medication posing undue risk per investigator judgment.
  • Started estrogen therapies for vulvovaginal symptoms within 3 months before inclusion.
  • Under treatment for infection.
  • Under treatment with aspirin, anticoagulants, platelet inhibitors, NSAIDs, immunosuppressants, Vitamin C within one week before inclusion.
  • Using local hydrating treatment within four weeks before inclusion.
  • History of correction with resorbable implants within 12 months before inclusion.
  • History of correction with permanent or semi-permanent implants in injection area.
  • Surgery on labia minora within 12 months before inclusion.
  • Surgery on labia majora at any time.
  • Intolerance to gram-positive bacteria.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Cabinet renaissance

Levallois-Perret, Paris, France, 92300

Actively Recruiting

2

Palais Flore

Lyon, France, 69006

Actively Recruiting

3

Medical Center "Tu sie leczy"

Gdansk, Gdansk, Poland

Actively Recruiting

Loading map...

Research Team

D

Dalia Quwaider, PhD, MBA

CONTACT

V

Vanesa Garrido Estevez, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation | DecenTrialz